Johnson & Johnson Careers
Associate Director, Global Market Access and Health Policy, ONCOLOGY
Requisition ID: 00001DJR
Janssen Global Commercial Strategy Organization-Oncology Therapeutic Area, a group within Janssen Global Services and a member of Johnson & Johnson's family of companies, is recruiting for an Associate Director, Global Market Access and Health Policy, ONCOLOGY. This position can be based in Raritan, NJ; High Wycombe, England; Toronto, Canada. The job will require up to 20% domestic and international travel.
At the Janssen Pharmaceutical Companies of Johnson & Johnson, what matters most is helping people live full and healthy lives. We focus on treating, curing and preventing some of the most devastating and complex diseases of our time. And we pursue the most promising science, wherever it might be found. We are Janssen. Our mission drives us. Our patients inspire us. We collaborate with the world for the health of everyone in it.
Janssen Global Services,
LLC encompasses groups that provide leadership across critical business areas
for Janssen including, Global Commercial Strategy Organization; Global
Pharmaceuticals Communication and Public Affairs; U.S. Pharmaceuticals
Procurement Group; and Pharmaceuticals Group Business Development. Global Market Access &
Health Policy works in collaboration with Global Strategic Marketing, Research
& Development, and our Operating Companies around the Globe to enable
worldwide patient access to our healthcare innovations.
Our vision for the future of Janssen Oncology is as a leader in payer-oriented commercial solutions while maintaining the ideals of a patient-focused, socially responsible and commercially successful company. This depends on our internal environment where the evolving needs of the marketplace are used as the guide to product development and commercialization.
• Support Compound Market Access Lead (CMAL) for strategic planning and implementation of the payer value generation and access strategies for assigned products and/or indications.
• Drive the design and management of health outcomes studies for the indication including: systematic literature reviews, Real World Evidence studies, and user-friendly cost effectiveness and budget impact models that can be adapted for coordinated delivery to key decision makers.
• Interact with Regional Market Access/Health Economics / Outcomes Research and Medical Affairs teams to coordinate and develop real world evidence generation in support of their access programs.
•Provide leadership to the indication specific clinical working group (CWG) in terms of market access data needs related to the clinical development plan.
• Act as part of cross-functional Global Indication Team with Global Commercial & Medical Affairs and ensure appropriate evidences are generated to develop robust differentiable value proposition for the indication at launch and during life cycle management.
•Foster collaboration and seamless working with Global and regional HEMAR partners as well as functions in Global Market Access HUB including PRO, Modeling , RWE and Analytics; making sure that priorities are jointly agreed so that deliverables are agreed and expectations managed.
• Take indication specific budgetary responsibility, ensuring that spending is managed effectively throughout the year and to plan.
•Keep up to date with scientific developments, bringing the latest techniques and analyses to build the strongest possible value proposition.
•Understand the patient perspective of the disease and recommend strategies that can support the patient voice in key payer negotiations.
• Must have a minimum of a Master's degree in appropriate field
(Science, Economics, Biostatistics ,Epidemiology, Health Economics, or Public
• A minimum of 6 year in Health Economics and Outcomes Research or Market Access is required.
• A thorough understanding of pharmaceutical commercialization and drug development process is required.
• Prior oncology experience is preferred.
• The successful candidate will have superior communication and strong interpersonal skill, demonstrated through working within cross-functional teams.
• An understanding of and/or experience with the reimbursement environment for key international markets is required.
• Experience with developing and submission of Reimbursement & Pricing dossiers to key government and private HTA and payer authorities are preferred.
United States-New Jersey-Raritan
North America-Canada-Ontario-Toronto, Europe/Middle East/Africa-United Kingdom-England-High Wycombe
Janssen Global Services, LLC (6085)
Health Economics R&D